The cause of scleroderma is unknown. People with this condition have a build up of a substance called collagen in the skin and other organs. This build up leads to the symptoms associated with the disease.
The disease usually affects people 30 to 50 years old. Women get scleroderma more often than men do. Risk factors include occupational exposure to silica dust and polyvinyl chloride.
Symptoms
Skin symptoms may include:
Blanching, blueness, or redness of fingers and toes in response to heat and cold (Raynaud's phenomenon)
Hair loss
Skin hardness
Skin is abnormally dark or light
Skin thickening and shiny hands and forearm
Small white lumps beneath the skin
Tight and mask-like facial skin
Ulcerations on fingertips or toes
Bone and muscle symptoms may include:
Joint pain
Numbness and pain in the feet
Pain, stiffness, and swelling of fingers and joints
Other treatments for specific symptoms may include:
Antacids for heartburn
Blood pressure medications (particularly ACE inhibitors) for high blood pressure or kidney problems
Medicines to improve breathing
Medications to treat Raynaud's phenomenon
Treatment usually includes a combination of physical therapy and skin and joint protection techniques (for example, avoiding cold in the case of Raynaud's phenomenon).
In most patients, the disease slowly gets worse. People who only have skin involvement have a better outlook. Death may occur from gastrointestinal, heart, kidney, or lung involvement.
One type of scleroderma, called localized scleroderma, involves only problems of the skin of the hands and face. It gets worse very slowly and usually does not affect any other parts of the body.
Systemic scleroderma can involve many organs in the body. In some people, it will progress slowly and not involve any organs in the body. In others, organs such as the lungs, kidneys, intestines, gallbladder, and heart become involved.
For some, symptoms and problems develop quickly over the first few years, and continue to worsen. Others get worse much more slowly. Problems with the lungs are the most common cause of death in patients with scleroderma.
Clouse RE, Diamant NE. Esophageal Motor and Sensory Function and Motor Disorders of the Esophagus. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2006: chap 41.
Review Date:
2/22/2009
Reviewed By:
Ariel D. Teitel, MD, MBA, Chief, Division of Rheumatology, St. Vincent’s Hospital, New York, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.